Literature DB >> 7872714

p53 expression and poor prognosis in childhood acute lymphoblastic leukemia.

S Hecker1, A Sauerbrey, M Volm.   

Abstract

Ninety-one children with untreated acute lymphoblastic leukemia (ALL) were analysed for expression of p53 using immunocytochemistry. p53 expression was found in 80% of the cases by Mab 421. Kaplan-Meier estimates show that patients with p53-positive leukemic cells had significantly shorter survival times under chemotherapy than those with p53-negative leukemic cells (p = 0.05, log-rank test). Statistical analysis revealed no correlation between p53 expression and patient's age, sex, immunotyping and initial peripheral blast cell count.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7872714

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  The importance of phase I/II trials in pediatric oncology.

Authors:  C A MacArthur; T Vietti
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

Review 2.  Resistance to chemotherapeutic antimetabolites: a function of salvage pathway involvement and cellular response to DNA damage.

Authors:  A R Kinsella; D Smith; M Pickard
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.